The Oncology Institute, Inc.

Equities

TOI

US68236X1000

Healthcare Facilities & Services

Real-time Estimate Cboe BZX Other stock markets 20:18:43 05/06/2024 BST			5-day change	1st Jan Change
0.45 ^USD	-0.09%		-5.97%	-77.92%

05-14	Transcript : The Oncology Institute, Inc., Q1 2024 Earnings Call, May 14, 2024
05-14	The Oncology Institute, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Tranche Update on The Oncology Institute, Inc.'s Equity Buyback Plan announced on June 15, 2023.

August 09, 2023 at 09:28 pm

From June 14, 2023 to June 30, 2023, the company has repurchased 1,593,128 shares, representing 2.11% for $0.89 million. With this, the company has completed the repurchase of 1,593,128 shares, representing 2.11% for $0.89 million under the buyback announced on June 15, 2023.

Latest news about The Oncology Institute, Inc.

Transcript : The Oncology Institute, Inc., Q1 2024 Earnings Call, May 14, 2024	05-14
The Oncology Institute, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-14	CI
Earnings Flash (TOI) TOI MANAGEMENT LLC Reports Q1 Revenue $94.7M, vs. Street Est of $95.2M	05-14	MT
(TOI) TOI MANAGEMENT LLC Sees Fiscal Year 2024 Revenue Range $400M - $415M	05-14	MT
The Oncology Institute, Inc. Reaffirms Earnings Guidance for the Year 2024	05-14	CI
The Oncology Institute, Inc. Appoints Jordan McInerney as New Chief Development Officer	04-08	CI
The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California	04-04	CI
Transcript : The Oncology Institute, Inc., Q4 2023 Earnings Call, Mar 27, 2024	03-27
The Oncology Institute Q4 Loss Widens, Revenue Increases	03-27	MT
(TOI) THE ONCOLOGY INSTITUTE Forecasts Fiscal Year 2024 Revenue Range $400M - $415M	03-27	MT
Earnings Flash (TOI) THE ONCOLOGY INSTITUTE Posts Q4 Revenue $85.8M	03-27	MT
The Oncology Institute, Inc. Provides Earnings Guidance for the Year 2024	03-27	CI
The Oncology Institute, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	03-26	CI
MaxHealth & The Oncology Institute, Inc. Expand Value-Based Care Partnership	03-14	CI
The Oncology Institute Expands Its Specialty Medication Business by Opening Pharmacy Operations in California	12-04	CI
Oncology Institute Insider Sold Shares Worth $118,581, According to a Recent SEC Filing	11-16	MT
Transcript : The Oncology Institute, Inc., Q3 2023 Earnings Call, Nov 08, 2023	11-08
Tranche Update on The Oncology Institute, Inc.'s Equity Buyback Plan announced on August 30, 2023.	11-08	CI
Tranche Update on The Oncology Institute, Inc.'s Equity Buyback Plan announced on June 15, 2023.	11-08	CI
The Oncology Institute, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-08	CI
Earnings Flash (TOI) TOI MANAGEMENT LLC Reports Q3 Revenue $82M, vs. Street Est of $74.7M	11-08	MT
The Oncology Institute, Inc. Reaffirms Earnings Guidance for the Year 2023	11-08	CI
The Oncology Institute Reports Goodwill Impairment Charge for the Nine Months Ended 2023	11-08	CI
The Oncology Institute, Inc. Names Jeremy Castle as Chief Operations Officer	11/10/23	CI
The Oncology Institute Appoints Jeremy Castle as Chief Operations Officer	11/10/23	MT

Chart The Oncology Institute, Inc.

Duration

Period

More charts

Company Profile

The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at 83 clinic locations across 15 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, radiation, programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. It also provides management services to 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.

Sector

Healthcare Facilities & Services

Calendar

06/06/2024 - Jefferies Global Healthcare Conference

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.4504 USD

Average target price

2 USD

Spread / Average Target

+344.05%

Consensus

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
THE ONCOLOGY INSTITUTE, INC.	-77.92%	33.53M
HCA HEALTHCARE, INC.	+24.33%	86.96B
CVS HEALTH CORPORATION	-23.36%	75.65B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+0.49%	26.97B
FRESENIUS SE & CO. KGAA	+5.59%	17.89B
LABCORP HOLDINGS INC.	-12.50%	16.58B
QUEST DIAGNOSTICS INCORPORATED	+3.30%	15.73B
NATERA, INC.	+77.98%	13.01B
TENET HEALTHCARE CORPORATION	+80.67%	12.92B
DAVITA INC.	+38.73%	12.57B

Other Healthcare Facilities & Services